PT Darya-Varia Laboratoria Tbk (IDX: DVLA)
Health Care · Pharmaceuticals · ID
Rp1,585.00
+0.32% today · -2.2% 1Y
PT Darya-Varia Laboratoria Tbk (IDX: DVLA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $99.21M and employs 1,357 people.
Over the last twelve months the share price has lost 2.2%, trading between 1.45K and 1.72K.
Tweenvest scores PT Darya-Varia Laboratoria Tbk across four factors: quality 86/100, value 64/100, dividend 100/100. Its strongest factor is dividend.
DVLA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $99.21M
- Revenue (TTM)
- $131.60M
- P/E
- 13.03
- EPS
- 121.63
- Dividend yield
- 6.62%
- Beta (5Y)
- -0.09
- 52-week high
- Rp1,715.00
- 52-week low
- Rp1,450.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.12B
- Employees
- 1,357
- Next earnings
- —
About PT Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk is an Indonesian enterprise dedicated to the production and commercialization of pharmaceutical goods and cosmetic items. Its operations are organized into three primary divisions: prescription medications, consumer health products, and services for export and contract manufacturing. The company offers a comprehensive selection of both prescribed and over-the-counter health solutions, addressing categories like antibiotics, antiparasitics, antiseptics, antifungals, treatments for coughs and colds, cardiovascular conditions, central nervous system disorders, gastrointestinal and liver ailments, somatic issues, vitamins and dietary supplements, women's health, ear care, and dermatological concerns. Beyond its domestic activities, the firm also distributes its products internationally to nations such as Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. Established in 1976, PT Darya-Varia Laboratoria Tbk is headquartered in Jakarta, Indonesia, and functions as a subsidiary of Blue Sphere Singapore Pte. Ltd.
- ISIN
- ID1000117203
- Founded
- 1976
- Listed since
- Dec 13, 2001
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| RaQualia Pharma Inc.TSE: 4579 | $100.94M | ¥614.00 | +0.82% |
| Intech Biopharm CorporationTPEX: 6461 | $100.75M | NT$29.20 | +10.40% |
| Grown Rogue International Inc.CNSX: GRIN | $99.85M | CA$0.57 | +3.64% |
| Polaryx Therapeutics, Inc.NasdaqCM: PLYX | $99.69M | $1.97 | -1.50% |
| Kyongbo Pharmaceutical Co., LtdKOSE: A214390 | $97.81M | ₩5,500.00 | +1.48% |
| Infant Bacterial Therapeutics AB (publ)OM: IBT B | $97.54M | Skr72.40 | +4.17% |
| The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM | $97.38M | JD1.52 | -1.30% |
| SAMSUNG PHARM. Co., LTD.KOSE: A001360 | $96.33M | ₩1,376.00 | -3.98% |
Figures last refreshed Oct 11, 2026.